Loomis, Sayles & Company’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,082,225
| Closed | -$41.1M | – | 1013 |
|
|
2023
Q4 | $41.1M | Sell |
1,082,225
-34,259
| -3% | -$1.3M | 0.06% | 144 |
|
|
2023
Q3 | $20.5M | Sell |
1,116,484
-34,847
| -3% | -$639K | 0.04% | 238 |
|
|
2023
Q2 | $29.9M | Sell |
1,151,331
-10,651
| -0.9% | -$277K | 0.05% | 190 |
|
|
2023
Q1 | $21.9M | Buy |
1,161,982
+161,176
| +16% | +$3.04M | 0.04% | 223 |
|
|
2022
Q4 | $24.7M | Sell |
1,000,806
-23,938
| -2% | -$590K | 0.05% | 198 |
|
|
2022
Q3 | $18.4M | Sell |
1,024,744
-11,551
| -1% | -$207K | 0.04% | 220 |
|
|
2022
Q2 | $11.8M | Sell |
1,036,295
-4,120
| -0.4% | -$46.8K | 0.02% | 335 |
|
|
2022
Q1 | $23.2M | Buy |
+1,040,415
| New | +$23.2M | 0.03% | 268 |
|